Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
What stool test results mean
Stool test results reveal three main categories of digestive health information. Infectious agents include bacteria like Salmonella or C. difficile, parasites such as Giardia, and viruses that may be associated with gastroenteritis. A positive result means these organisms are present and likely causing symptoms.
Inflammatory markers measure proteins released when your intestinal lining becomes irritated. Calprotectin levels above 50 micrograms per gram may suggest active inflammation. Lactoferrin, another inflammatory protein, may indicate immune system activation in your gut.
Blood detection comes in two forms: visible blood you can see, and occult (hidden) blood detected only through chemical testing. Both types may suggest bleeding somewhere in your digestive tract, from minor irritation to more serious conditions.
Digestive function tests measure how well you break down and absorb nutrients. Fat in stool (steatorrhea) may suggest pancreatic enzyme deficiency or bile acid problems. Low elastase levels may indicate poor pancreatic function.
How to interpret stool test results
Reading stool test results requires understanding reference ranges and clinical significance. Most testing reports show results as "negative," "positive," or provide numerical values with normal ranges.
For infectious agents, any positive result typically requires treatment. However, some people carry certain bacteria without symptoms (asymptomatic carriers). Your care team considers your symptoms alongside test results.
Inflammatory markers use numerical thresholds. Calprotectin below 50 μg/g is generally considered normal, 50-200 μg/g may suggest mild inflammation, and above 200 μg/g could indicate significant intestinal inflammation associated with conditions like inflammatory bowel disease.
Blood tests are binary: present or absent. Even trace amounts warrant investigation. The location and amount of bleeding determine urgency, but all positive results need medical evaluation.
Digestive enzymes have specific ranges. Pancreatic elastase below 200 μg/g may suggest pancreatic insufficiency. Fat content above 7 grams per day may indicate malabsorption.
What can influence stool test results
Multiple factors can skew stool test results, creating false positives or masking real issues. Dietary choices in the 72 hours before testing significantly impact results. Red meat, iron supplements, and vitamin C can affect blood detection tests.
Medications alter gut bacteria and inflammation markers. Antibiotics taken within 2-4 weeks can eliminate target bacteria, creating false negatives. NSAIDs (ibuprofen, naproxen) may be associated with intestinal bleeding and elevated inflammatory markers.
Sample collection timing matters crucially. Contamination with urine, toilet water, or menstrual blood invalidates results. Samples older than 24-48 hours may not accurately reflect bacterial populations.
Recent illness or stress can temporarily elevate inflammatory markers. Your immune system activation from any cause can increase calprotectin and lactoferrin levels, even without primary gut inflammation.
Probiotic supplements can introduce non-pathogenic bacteria that might be detected in some tests, though they rarely interfere with pathogen-specific testing.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Related context that changes the picture
Stool test results gain meaning when viewed alongside other health markers. Blood inflammatory markers like C-reactive protein and erythrocyte sedimentation rate (ESR) help distinguish local gut inflammation from systemic inflammation.
Nutrient absorption markers in blood work complement stool testing. Low vitamin B12, folate, or fat-soluble vitamins (A, D, E, K) may support stool findings of malabsorption. Iron deficiency anemia alongside positive occult blood may suggest chronic gastrointestinal bleeding.
Immune system markers provide additional context. Low IgA levels can predispose you to gut infections, while elevated eosinophils might suggest parasitic infections that stool testing may help identify.
Hormonal factors influence digestive function and test interpretation. Thyroid disorders affect gut motility and can alter stool consistency and transit time. Cortisol elevation from chronic stress impacts gut barrier function and inflammatory responses.
Food sensitivity testing may help explain persistent symptoms when stool tests are negative for pathogens but show inflammation. IgG food antibodies or elimination diet results can guide dietary modifications that may help reduce gut inflammation.
Take control of your digestive health
Understanding your stool test results is just the beginning. The real insight comes from seeing how your digestive markers connect with your overall metabolic and inflammatory status.
Superpower's comprehensive health panels include digestive health markers alongside complete blood biomarker analysis. You'll see how gut inflammation relates to your immune function, nutrient absorption, and metabolic health. This complete picture helps you and your care team make targeted interventions that address root causes, not just symptoms.
Explore Superpower's health testing options to get the full context your digestive health deserves.
Frequently Asked Questions
References
- Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK (2017). 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. *Clinical infectious diseases : an official publication of the Infectious Diseases Society of America*, *65*(12), 1963-1973. https://doi.org/10.1093/cid/cix959
- Rokkas T, Portincasa P, Koutroubakis IE (2018). Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis. *Journal of gastrointestinal and liver diseases : JGLD*, *27*(3), 299-306. https://doi.org/10.15403/jgld.2014.1121.273.pti
- Khan AU, Mandiga P (2023). *Gastrointestinal bleeding scan*. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK544317/
- González-Sánchez V, Amrani R, González V, Trigo C, Picó A, de-Madaria E (2017). Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis:. *Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]*, *17*(4), 580-585. https://doi.org/10.1016/j.pan.2017.03.002
- Roslani AC, Abdullah T, Arumugam K (2012). Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction. *Asian Pacific journal of cancer prevention : APJCP*, *13*(1), 237-41. https://doi.org/10.7314/apjcp.2012.13.1.237
- Koch K, Campanella C, Baidoo CA, Manzo JA, Ameen VZ, Kersey KE (2004). Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex). *Digestive diseases and sciences*, *49*(7-8), 1244-9. https://doi.org/10.1023/b:ddas.0000037819.31817.7c
- Philpott H, Nandurkar S, Lubel J, Gibson PR (2013). Alternative investigations for irritable bowel syndrome. *Journal of gastroenterology and hepatology*, *28*(1), 73-7. https://doi.org/10.1111/j.1440-1746.2012.07291.x
- Bathobakae L, Rivera E, Mücahit D, John R, Atogwe I, Phuu P, Escobar J, Bandaru P, Cavanagh Y, Ligresti R, Robinson MK (2026). Pancreatic Exocrine Insufficiency After Metabolic and Bariatric Surgery. *Digestive diseases and sciences*, *71*(1), 95-108. https://doi.org/10.1007/s10620-025-09325-z
- Nicholson MR, Ma S, Strickland BA, Cecala M, Zhang L, Reasoner S, Guiberson ER, Munneke MJ, Shilts MH, Skaar EP, Das SR (2026). The Gut Microbiome and Butyrate Differentiate Clostridioides difficile Colonization and Infection in Children. *The Journal of infectious diseases*, *233*(3), e812-e822. https://doi.org/10.1093/infdis/jiaf631
- Jaffe RM, Kasten B, Young DS, MacLowry JD (1975). False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). *Annals of internal medicine*, *83*(6), 824-6. https://doi.org/10.7326/0003-4819-83-6-824
- Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M, Tokioka S, Arakawa T (2009). Present status and strategy of NSAIDs-induced small bowel injury. *Journal of gastroenterology*, *44*(9), 879-88. https://doi.org/10.1007/s00535-009-0102-2
- La Torre D, Van Oudenhove L, Vanuytsel T, Verbeke K (2023). Psychosocial stress-induced intestinal permeability in healthy humans: What is the evidence?. *Neurobiology of stress*, *27*, 100579. https://doi.org/10.1016/j.ynstr.2023.100579
- Malícková K, Kalousová M, Fucíková T, Bortlík M, Duricová D, Komárek V, Zima T, Janatková I, Lukás M (2010). Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes. *Scandinavian journal of clinical and laboratory investigation*, *70*(4), 294-9. https://doi.org/10.3109/00365513.2010.485648
- Swain S, Selmi C, Gershwin ME, Teuber SS (2019). The clinical implications of selective IgA deficiency. *Journal of translational autoimmunity*, *2*, 100025. https://doi.org/10.1016/j.jtauto.2019.100025
- Martínez-Vallejo P, Mediavilla A, Silgado A, Zarzuela F, Goterris L, Maturana CR, Serre-Delcor N, Oliveira-Souto I, Salvador F, Joseph-Munne J, Aznar ML, Pou D, Treviño B, Molina I, Sotillo J, Sulleiro E (2025). Evaluation of molecular and serological testing for imported urogenital schistosomiasis screening in a referral tropical medicine centre in Barcelona, Spain. *Parasites & vectors*, *18*(1), 196. https://doi.org/10.1186/s13071-025-06832-w
- Kubiszewski K, Chapman RW, Piazza Y, Patel D, Neychev V (2023). Hypothyroidism Presenting as Adynamic Ileus Mimicking a Mechanical Small Bowel Obstruction: A Diagnostic and Management Dilemma. *Cureus*, *15*(12), e50799. https://doi.org/10.7759/cureus.50799
- Klein EJ, Stapp JR, Clausen CR, Boster DR, Wells JG, Qin X, Swerdlow DL, Tarr PI (2002). Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. *The Journal of pediatrics*, *141*(2), 172-7. https://doi.org/10.1067/mpd.2002.125908
- Johansen, Ø. H., Abdissa A, Zangenberg M, Mekonnen Z, Eshetu B, Bjørang O, Alemu Y, Sharew B, Langeland N, Robertson LJ, Hanevik K (2021). Performance and operational feasibility of two diagnostic tests for cryptosporidiosis in children (CRYPTO-POC): a clinical, prospective, diagnostic accuracy study. *The Lancet. Infectious diseases*, *21*(5), 722-730. https://doi.org/10.1016/S1473-3099(20)30556-9














